CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Learn about various ways to earn quick cash today with fast and effective solutions that fit your lifestyle. Start boosting your finances!
23,277 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Not all tech stocks pay dividends, but a small group do. Here are two reliable picks that blend growth with income, p...
As Palantir hype cools, two AI-driven cash-flow engines emerge as steadier bets. This report explains why Alphabet an...
As Berkshire's new leader, Greg Abel faces a massive cash pile. This article examines why Alphabet is the target, wha...
NVIDIA is expanding beyond chips into cloud AI infrastructure. This move signals a broader AI ecosystem pivot that co...
In 2026, workers using AI are finishing tasks faster, but broad productivity data remains subdued. Economists compare...
Oil prices hold steady near $78 a barrel as July 2026 begins. Traders weigh demand, supply risks, and policy shifts t...
Oil prices climbed after OPEC+ extended production cuts, pushing Brent above $100 as of March 13, 2026. The current p...
Bitcoin remains volatile as ETF outflows and higher rates weigh on demand. This report weighs the case for worth inve...
SK Hynix’s record Nasdaq debut raises $26.5 billion, underscoring persistent AI memory demand as markets grapple with...
Retirement health costs can surprise you. This guide reveals five Medicare myths that costing seniors thousands and p...
Bitcoin slid below the $73,000 level as Stellar posted a near-19% gain, highlighting a split in crypto markets amid m...